Annals of Translational Medicine · 2019 · 17 citations · 24 references
Life SciencesCell BiologyImmunologyImmunoregulationInflammationTransplant ImmunologyAcute RejectionCell-mediated ImmunityCytokine BiologyDendritic Cell BiologyDendritic Cell RegulationTransplant RejectionBiomarkers Of Acute RejectionCd4 Positive T CellsInterleukin-17 PathwayLiver Transplant RejectionMhc Class Ii MoleculesT Helper 17 DifferentiationTh17 Cell DifferentiationWestern Blot Analysis
Background: This study aimed to investigate the mechanism of galectin (Gal)-1 of regulating Treg/Th17 in pathogenesis of acute rejection after liver transplantation in rat. Methods: Mononuclear cells were induced to immature dendritic cells (imDCs), which were transfected with or without NF-κB/RelB. Western Blot was performed to detect the expression of NF-κB/RelB. the expression of CD11c, CD45RB, CD80 and MHC II were detected by flow cytometry. Enzyme-linked immunosorbent assay (ELISA) was employed to detect cytokines IL-27 and TGF-β. Lewis and dark agouti (DA) rats were generally anaesthetized by isoflurane inhalation to establish liver transplant models. Results: We demonstrate that Gal-1 disturbs maturation of imDCs by downregulating NF-κB/RelB expression, and Gal-1 negatively controls CD4+ proliferation though IL-27 pathway. Conclusions: In aggregate, Gal-1 promotes Treg differentiation in CD4+ T cells though NF-κB/RelB-IL-27 pathway. These findings suggest a new therapeutic target to mediate Treg population.
24
Juan M. Ilarregui, Diego O. Croci, Germán A. Bianco et al. · Nature Immunology · 2009 · 470 citations · Full text